tiprankstipranks
Trending News
More News >
JB Chemicals & Pharmaceuticals Ltd. (IN:JBCHEPHARM)
:JBCHEPHARM
India Market
Advertisement

JB Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) Price & Analysis

Compare
3 Followers

JBCHEPHARM Stock Chart & Stats


JBCHEPHARM FAQ

What was JB Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
JB Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹1303.00 and its highest was ₹2029.00 in the past 12 months.
    What is JB Chemicals & Pharmaceuticals Ltd.’s market cap?
    JB Chemicals & Pharmaceuticals Ltd.’s market cap is ₹259.32B.
      When is JB Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
      JB Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 06, 2025 which is in 89 days.
        How were JB Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
        JB Chemicals & Pharmaceuticals Ltd. released its earnings results on Jul 30, 2025. The company reported ₹13.7 earnings per share for the quarter, beating the consensus estimate of ₹13.6 by ₹0.1.
          Is JB Chemicals & Pharmaceuticals Ltd. overvalued?
          According to Wall Street analysts JB Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does JB Chemicals & Pharmaceuticals Ltd. pay dividends?
            JB Chemicals & Pharmaceuticals Ltd. pays a Semiannually dividend of ₹7 which represents an annual dividend yield of 0.92%. See more information on JB Chemicals & Pharmaceuticals Ltd. dividends here
              What is JB Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
              JB Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does JB Chemicals & Pharmaceuticals Ltd. have?
              JB Chemicals & Pharmaceuticals Ltd. has 156,318,010 shares outstanding.
                What happened to JB Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
                JB Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹13.7 in its last earnings report, beating expectations of ₹13.6. Following the earnings report the stock price went down -0.699%.
                  Which hedge fund is a major shareholder of JB Chemicals & Pharmaceuticals Ltd.?
                  Currently, no hedge funds are holding shares in IN:JBCHEPHARM

                  Company Description

                  JB Chemicals & Pharmaceuticals Ltd.

                  J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.

                  JB Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Ajanta Pharma Limited
                  Emcure Pharmaceuticals Limited
                  Gland Pharma Ltd.
                  Glenmark Pharmaceuticals Limited
                  PFIZER LIMITED
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis